ArticleDrug delivery and translational research2025

Dual acting oxaliplatin (IV) prodrug loaded albumin nanoparticles for safer synergistic anticancer action against triple negative breast cancer.

Kshitija Abhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.